HV-101 / Hervor Therap, TCRCure - LARVOL DELTA

HV-101 for Patients With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=1 | Terminated | Sponsor: Hervor Therapeutics | N=18 ➔ 1 | Recruiting ➔ Terminated; Portfolio prioritization

Enrollment change • Trial termination • Solid Tumor

HV-101 for Patients With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=18 | Recruiting | Sponsor: Hervor Therapeutics | Phase classification: P1/2 ➔ P1

Metastases • Phase classification • Oncology • Solid Tumor